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13.0×10
9 /L); Hb, 9.1 g/dL; and platelet count, 99.0×10 9 /L.
In addition, parasite antibodies for Clonorchis sinensis, Paragonimus westermani, Cysticercus cellulosae, and Sparganosis were negative. The number of eosinophils in the peripheral blood smear was increased (Fig. 1A) . Analysis of the bone marrow aspirate showed that 1.95% of all nucleated cells were blasts and eosinophils were increased (Fig. 1B) . Conventional cytogenetic analysis revealed a normal karyotype (46,XY). Fluorescence in situ hybridization (FISH) for FIP1L1-PDGFRA using the Vysis 4q12 Tri-Color probe (Abbott, Des Plaines, USA) was positive ( Fig. 2A,   B ). We confirmed the FIP1L1-PDGFRA rearrangement by reverse transcription-polymerase chain reaction (RT-PCR) and sequencing analysis (Fig. 2D, E /L. The number of eosinophils in the peripheral blood smear was increased (Fig. 1C) . In the bone marrow aspirate, 90% of all nucleated cells were eosinophils. Infiltration by eosinophils was observed in the bone marrow section (Fig. 1D) . Conventional cytogenetic analysis revealed a normal karyotype (46,XY) and FISH for FIP1L1-PDGFRA was positive (Fig. 2C) . Tyrosine kinase inhibitor treatment with imatinib mesylate was initiated and the eosinophil counts decreased.
DISCUSSION
The FIP1L1-PDGFRA rearrangement caused by a cryptic deletion of 800-kb on chromosome 4q12, which contains the CHIC2 gene [2] , cannot be detected in conventional chromosomal studies; FISH or RT-PCR must be used. The prevalence of PDGFRA, PDGFRB or FGFR1 rearrangements is generally low. The FIP1L1-PDGFRA rearrangement is the most commonly found with an incidence of approximately 23%, but this varies (range, 3-56%) depending on the HES patient population [3] , and is predominantly found in males. In a Korean study [4] , only 1 case with a PDGFRA Letters to the Editor Abbreviations: AMML, acute myelomonocytic leukemia; CEL, chronic eosinophilic leukemia; CMML, chronic myelomonocytic leukemia; MD, minimal differentiation; MM, multiple myeloma; NA, not available.
rearrangement was detected among 34 hypereosinophilia patients who were suspected of having clonal eosinophilia.
Until now, few cases of PDGFRA, PDGFRB, or FGFR1 rearrangements have been reported in Korea [4] [5] [6] [7] [8] [9] , and these are summarized in Table 1 .
The initial clinical manifestation of HES involves dermatologic, pulmonary, and gastrointestinal symptoms [10] . However, the presence of neurologic or cardiac signs and symptoms increases with disease progression or delayed diagnosis [10] . Severe cardiac complications include endomyocardial fibrosis, valve scarring, and embolism. Our patients also showed dyspnea, cardiac signs (valve regurgitation), and renal involvement (Case 1). Therefore, clinicians need to be alert for the presence PDGFRA, PDGFRB, or FGFR1 rearrangements in eosinophilia patients with systemic symptoms, especially those associated with the cardiopulmonary or renal systems.
In conclusion, we report 2 cases of CEL with the FIP1L1-PDGFRA rearrangement. Eosinophilia with PDGFRA, PDGFRB, or FGFR1 rearrangements is rare in the general population. However, its prevalence is high in HES patients (range, 3-56%) [3] , and FISH or RT-PCR must be used for its detection. Unusual cardiopulmonary or gastrointestinal symptoms with severe complications may be observed initially. . Paraproteinemia is associated with about 20% of patients with indolent types of NHL, whereas it appears to be rare in aggressive lymphomas [1] . Immunofixation (IFX) and conventional serum protein electrophoresis (SPEP) are useful tools to detect even low levels of monoclonal Igs. Herein, we report a case of diffuse large B cell lymphoma with a very high level of IgG kappa monoclonal gammopathy, which was rarely reported in the literature [2] .
CASE
A 68-year-old man with a known case of rheumatoid arthritis presented with upper gastrointestinal bleeding. On examination, he was found to have axillary lymphadenopathy with splenomegaly. F-18 fluoro-D-glucose (FDG) positron emission tomography showed FDG avid bilateral axillary, external iliac, and inguinal lymph nodes and splenomegaly with diffusely increased FDG uptake. Hematological analysis showed hemoglobin to be 7.7 g/L; total leucocyte count, 8.9×10 9 /L; and platelets, 80×10 9 /L. Axillary lymph node biopsy showed sheets of large atypical lymphoid cells with irregular contours, brisk mitoses, and prominent nucleoli as well as perinodal spread. According to immunohistochemical analysis, these cells were positive for CD20 and MUM-1 and negative for CD3, CD10, Bcl-6, CD5, and cyclin D1. The Ki-67 index was found to be 70% (Fig. 1) . A final diagnosis of diffuse large B cell lymphoma (DLBCL) was made, and bone marrow examination was performed for staging. Bone marrow preparation showed approximately 25% lymphoid cells including few abnormal forms, suggestive of lymphoma infiltration; this was confirmed on bone marrow biopsy by the presence of CD20 positive lymphoid cells in a diffuse and nodular pattern. Furthermore, plasma cell percentage was not increased and no monoclonal population was noted on biopsy, which was confirmed by immunohistochemistry for kappa and lambda light chains. SPEP revealed a monoclonal M band of 4.66 g/dL (Fig. 1) , IFX identified this monoclonal protein to be IgG, kappa. A serum-free light chain assay showed the kappa level to be 325.98 mg/L, lambda 161.56 mg/L, and the ratio of kappa to lambda 2.0. A final diagnosis of stage IV DLBCL with paraproteinemia was made and the patient was started on R-CHOP therapy.
DISCUSSION
Paraproteinemia, or monoclonal gammopathy, is the presence of excessive amounts of paraprotein or a single monoclonal gammaglobulin in the blood. It usually occurs as a part of an underlying immunoproliferative disorder, such as leukemia, lymphoma, or plasma cell dyscrasia. Serum paraprotein levels in lymphoma patients are usually low and commonly associated with low grade lymphomas. Detection of monoclonal paraprotein using SPEP with quantitation of Igs and IFX should be included in the staging of lymphoma patients, as the presence of monoclonal gammopathy may influence prognostic stratification of these patients. Serum-free light chain assay is also a useful technique and may represent a significant prognostic marker for the detection of bulk and residual disease, both before and after treatment [3] . Further studies should be conducted to correlate the survival of these patients with the quantity and type of paraproteins and any requirement of a specific chemotherapeutic drug combination for improving overall survival. High M protein sometimes can lead to mislabeling of a case as plasma cell dyscrasia, delaying appropriate investigation. High paraprotein levels must not dissuade one from suspecting an underlying lymphoma, especially when relevant investigation for plasma cell dyscrasia is non-contributory Manavi Dang, Smeeta Gajendra, Shalini Goel, Bhawna Jha, Tushar Sahni, Ritesh Sachdev
Department of Pathology and Laboratory Medicine, Medanta-The Medicity, Gurgaon, India
